IP Library Assignment 052130/0980
Patent Assignment
Reel/Frame 052130/0980

Patent Security Agreement

Recorded: 2020-03-09 Pages: 10
Assignor
MENLO THERAPEUTICS INC.
Executed: 2020-03-09
Assignee
PERCEPTIVE CREDIT HOLDINGS II, LP
51 ASTOR PLACE, 10TH FLOOR, NEW YORK, NEW YORK, 10003
Covered Properties (19)
Hydroisoindoline Tachykinin Receptor Antagonists
Patent: 7,645,790 →
Application: 10/586,727 →
Publication: US 2008/0280966
Hydroisoindoline Tachykinin Receptor Antagonists
Patent: 7,217,731 →
Application: 11/043,213 →
Publication: US 2005/0165083
Hydroisoindoline Tachykinin Receptor Antagonists
Patent: 7,345,083 →
Application: 11/714,352 →
Publication: US 2007/0161695
Hydroxymethyl Ether Hydroisoindoline Tachykinin Receptor Antagonists
Patent: 8,124,633 →
Application: 12/593,168 →
Publication: US 2010/0105747
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 8,906,951 →
Application: 13/925,509 →
Publication: US 2014/0378521
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 9,198,898 →
Application: 14/312,942 →
Publication: US 2015/0057255
Use of Nk-1 Receptor Antagonist Serlopitant in Pruritus
Patent: 9,486,439 →
Application: 14/899,255 →
Publication: US 2016/0143882
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 9,381,188 →
Application: 14/922,684 →
Publication: US 2016/0038462
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 9,474,741 →
Application: 15/175,358 →
Publication: US 2016/0279100
Use of Nk-1 Receptor Antagonist Serlopitant in Pruritus
Patent: 9,737,507 →
Application: 15/269,792 →
Publication: US 2017/0065557
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 9,737,508 →
Application: 15/271,103 →
Publication: US 2017/0065558
Use of Nk-1 Receptor Antagonist Serlopitant in Pruritus
Patent: 9,974,769 →
Application: 15/626,001 →
Publication: US 2017/0348282
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 9,968,588 →
Application: 15/626,002 →
Publication: US 2017/0348283
Use of Nk-1 Receptor Antagonists in Pruritus
Application: 15/949,843 →
Publication: US 2018/0325866
Use of Nk-1 Receptor Antagonist Serlopitant in Pruritus
Application: 15/956,102 →
Publication: US 2018/0325867
Use of Neurokinin-1 Antagonists to Treat a Variety of Pruritic Conditions
Application: 16/312,900 →
Publication: US 2019/0216779
Use of Nk-1 Receptor Antagonist Serlopitant in Pruritus
Application: 16/364,075 →
Publication: US 2020/0054603
Use of Nk-1 Receptor Antagonists in Pruritus
Application: 16/364,078 →
Publication: US 2020/0054604
Use of Neurokinin-1 Antagonists to Treat Chronic Pruritus
Application: 62/821,126 →
Related Assignments (21)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Nov 24, 2009
From: MERCK & CO., INC
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023563/0437 →
Change of Name Jan 27, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023852/0595 →
Change of Name Jan 29, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023861/0910 →
Merger Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
Change of Name Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
Assignment of Assignor's Interest Jun 25, 2013
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 030681/0886 →
Assignment of Assignor's Interest Aug 22, 2014
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 033594/0099 →
Change of Name Jul 6, 2016
From: TIGERCAT PHARMA, INC.
To: MENLO THERAPEUTICS INC.
Reel/Frame 039197/0765 →
Assignment of Assignor's Interest May 5, 2017
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 042258/0517 →
Assignment of Assignor's Interest May 5, 2017
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 042259/0057 →
Change of Name May 5, 2017
From: TIGERCAT PHARMA, INC.
To: MENLO THERAPEUTICS INC.
Reel/Frame 042418/0481 →
Assignment of Assignor's Interest Sep 11, 2018
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 046842/0458 →
Assignment of Assignor's Interest Sep 11, 2018
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 046842/0424 →
Assignment of Assignor's Interest Sep 11, 2018
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 046842/0175 →
Change of Name Sep 11, 2018
From: TIGERCAT PHARMA, INC.
To: MENLO THERAPEUTICS INC.
Reel/Frame 047051/0187 →
Assignment of Assignor's Interest Jan 7, 2019
From: BASTA, STEVEN; JOING, MARK; ZHANG, XIAOMING; KWON, PAUL
To: MENLO THERAPEUTICS INC.
Reel/Frame 047922/0110 →
Change of Name May 3, 2019
From: TIGERCAT PHARMA, INC.
To: MENLO THERAPEUTICS INC.
Reel/Frame 049085/0793 →
Assignment of Assignor's Interest May 3, 2019
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 049077/0115 →
Change of Name Dec 1, 2020
From: MENLO THERAPEUTICS INC.
To: VYNE THERAPEUTICS INC.
Reel/Frame 054558/0437 →
Change of Name Jan 20, 2021
From: MENLO THERAPEUTICS INC.
To: VYNE THERAPEUTICS INC.
Reel/Frame 055042/0165 →
Release of Security Interest Sep 20, 2021
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: VYNE THERAPEUTICS INC. (F/K/A MENLO THERAPEUTICS INC. AND SUCCESSOR-IN-INTEREST TO VYNE PHARMACEUTICALS LTD., F/K/A FOAMIX PHARMACEUTICALS LTD.)
Reel/Frame 057531/0986 →